From: Prognostic significance of lymphangiogenesis in pharyngolaryngeal carcinoma patients
LARYNX | ILD | PLD | LVD) | Lymphatic Invasion | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Frequency | 57.41% (31/54) | 55.56% (30/54) | 87.04% (47/54) | 28.30% (15/53) | |||||||||
Mean (S.E.) | 10.59 (1.65) | 18.47 (2.03) | 18.98 (1.56) | ||||||||||
Score range | 0-41.56 | 0-60.45 | 0-44.71 | ||||||||||
N | Mean range | p# | N | Mean (S.E) | p¥ | N | Mean (S.E) | p¥ | Absent | Present | Total | p* | |
Anatomic site | |||||||||||||
Glottis | 30 | 23.45 | 0.028 | 30 | 15.22 (2.43) | 0.073 | 30 | 16.14 (2.06) | 0.042 | 23 | 6 | 29 | 0.176 |
Supraglottis | 24 | 32.56 | 24 | 22.54 (3.30) | 24 | 22.52 (2.24) | 15 | 9 | 24 | ||||
Total | 54 | 54 | 54 | 38 | 15 | 53 | |||||||
pT | |||||||||||||
T1-2 | 28 | 22.05 | 0.006 | 28 | 15.95 (2.85) | 0.2 | 28 | 15.98 (2.38) | 0.044 | 25 | 3 | 28 | 0.003 |
T3-4 | 26 | 33.37 | 26 | 21.19 (2.86) | 26 | 22.20 (1.84) | 13 | 12 | 25 | ||||
Total | 54 | 54 | 54 | 38 | 15 | 53 | |||||||
Nodal involvement | |||||||||||||
Free | 38 | 25.38 | 0.112 | 38 | 16.63 (2.23) | 0.165 | 38 | 17.72 (1.81) | 0.219 | 30 | 8 | 38 | 0.062 |
Affected | 16 | 32.53 | 16 | 22.85 (4.27) | 16 | 21.96 (3.03) | 8 | 7 | 15 | ||||
Total | 54 | 54 | 54 | 38 | 15 | 53 | |||||||
Tumour Stage | |||||||||||||
I-II | 24 | 20.92 | 0.004 | 24 | 13.95 (2.52) | 0.045 | 24 | 15.05 (2.35) | 0.023 | 20 | 4 | 24 | 0.073 |
III-IV | 30 | 32.77 | 30 | 22.09 (2.92) | 30 | 22.12 (1.94) | 17 | 11 | 28 | ||||
Total | 54 | 54 | 54 | 37 | 15 | 52 | |||||||
Recurrence | |||||||||||||
No | 43 | 28.35 | 0.169 | 43 | 17.02 (2.28) | 0.218 | 43 | 18.60 (1.80) | 0.685 | 29 | 13 | 42 | 0.492 |
Yes | 10 | 21.20 | 10 | 23.55 (4.7) | 10 | 20.28 (3.57) | 8 | 2 | 10 | ||||
Total | 53 | 53 | 53 | 37 | 15 | 52 |